Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/10945489

Download in:

View as

General Info

PMID
10945489